Filing Flows › Bristol Myers Squibb (BMY) › Net income
Bristol Myers Squibb (BMY) net income by quarter
Bristol Myers Squibb's net income was $2.2B in Q3 2026 (third quarter 2026), -35% from Q2 2026. Over the last 7 quarters it ranged from $1.1B (Q4 2025) to $3.3B (Q2 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.2B | -35% | -2% |
| Q2 2026 | $3.3B | +24% | +153% |
| Q1 2026 | $2.7B | +147% | +9% |
| Q4 2025 | $1.1B | -51% | — |
| Q3 2025 | $2.2B | +67% | — |
| Q2 2025 | $1.3B | -47% | — |
| Q1 2025 | $2.5B | — | — |
Q3 2026 at a glance
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Bristol Myers Squibb's net income?
Bristol Myers Squibb's net income was $2.2B in Q3 2026 (third quarter 2026), -35% from Q2 2026.
How has Bristol Myers Squibb's net income changed?
Over the last 7 quarters it ranged from $1.1B (Q4 2025) to $3.3B (Q2 2026).